Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Montana

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Cell|August 2, 2002
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognitionRandy K Bledsoe, Valerie G Montana, Thomas B Stanley, et al.
Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthmaGeorge M Buckley, Nicola Cooper, Hazel J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 inhibitors: a potential treatment for asthmaGeorge M Buckley, Nicola Cooper, Richard J Davenport, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthmaG Buckley, N Cooper, H J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
8-Methoxyquinolines as PDE4 inhibitorsMotasim Billah, George M Buckley, Nicola Cooper, et al.
Chemmedchem|September 29, 2011
Silicon analogues of the nonpeptidic GnRH antagonist AG-045572: syntheses, crystal structure analyses, and pharmacological characterizationMatthew J Barnes, Christian Burschka, Matthias W Büttner, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and profile of SCH351591, a novel PDE4 inhibitorMotasim Billah, Nicola Cooper, Francis Cuss, et al.
Journal of Medicinal Chemistry|January 25, 2007
Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agentsMichael L Sierra, Véronique Beneton, Anne-Bénédict Boullay, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cell|August 2, 2002
Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognitionRandy K Bledsoe, Valerie G Montana, Thomas B Stanley, et al.
Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthmaGeorge M Buckley, Nicola Cooper, Hazel J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 inhibitors: a potential treatment for asthmaGeorge M Buckley, Nicola Cooper, Richard J Davenport, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthmaG Buckley, N Cooper, H J Dyke, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
8-Methoxyquinolines as PDE4 inhibitorsMotasim Billah, George M Buckley, Nicola Cooper, et al.
Chemmedchem|September 29, 2011
Silicon analogues of the nonpeptidic GnRH antagonist AG-045572: syntheses, crystal structure analyses, and pharmacological characterizationMatthew J Barnes, Christian Burschka, Matthias W Büttner, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and profile of SCH351591, a novel PDE4 inhibitorMotasim Billah, Nicola Cooper, Francis Cuss, et al.
Journal of Medicinal Chemistry|January 25, 2007
Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agentsMichael L Sierra, Véronique Beneton, Anne-Bénédict Boullay, et al.
Pageof 6